Pharmaceuticals
-
Botox molecule could halt chronic nerve pain
A Botox-based treatment may have the potential to safely reduce chronic pain over the long term. Read more
-
NHS backs olaparib for breast and prostate cancer
A decision today to allow olaparib for NHS patients with both early-stage breast cancer and prostate cancer has been hailed a “life-changing” decision by leading specialists. Read more
-
‘Important’ cancer drug information often missing
Clinicians and cancer patients need better information on the benefits – and potential harms – of medicines, experts say today. Read more
-
Immunotherapy available for advanced cervical cancer
Patients with advanced cervical cancer are to get a new immunotherapy treatment in England, it was announced today. Read more
-
Immune system clue to reducing reliance on antibiotics
Antibiotic use could be lessened after scientists discovered have macrophage activity is essential for tackling infections such as TB. Read more
-
Malfunctioning immune cell linked to long COVID
The malfunctioning behaviour of an immune cell could be linked to specific symptoms of long COVID, opening the way to treatments, British researchers have reported. Read more
-
Common cough medicines withdrawn
The opioid pholcodine, a common component of cough and cold medicines, is to be removed from the British market, it was announced yesterday. Read more
-
New bone cancer drug unveiled
A new drug could treat the main types of primary bone cancer without toxic side effects, British researchers say. Read more
-
New drug for obese could cut stones
NHS specialist weight loss services are to have access to a drug which can reduce body weight by about 12%, it was announced today. Read more
-
Peptide to treat MND
A peptide given as a nasal spray might treat motor neurone disease, British scientists have suggested. Read more